Pandemic of Coronavirus 19: A Comprehensive Literature Review, Therapeutic Options and Possible Lessons from SARS-COV Therapy
Journal: Open Access Journal of Pharmaceutical Research (Vol.5, No. 2)Publication Date: 2021-04-02
Authors : Meher PS Rao JR; Sharma DK;
Page : 1-9
Keywords : Covid-19; Epidemiology; Pathogenesis; Favipiravir; Unani System;
Abstract
There are new public health emergencies debilitating world with the spread of the coronavirus disease 2019. This presents an inventive challenge to identify useful drugs for therapy. A new coronavirus was found in China, Wuhan city, in December 2019. A causative agent earlier termed COVID-19 by WHO. It affects lower respiratory tract and explicit as pneumonia in human. The disease transferred by inhalation or in contact with infected, surfaces. The evaluation and exposure to pathogenic organism period of virus in between 2 to 14 days. The common symptoms observed usually are cough, fever, fatigue and sore throat among others. Number of people is asymptomatic. The present review includes in detail information of virus, its epidemiology, symptoms, diagnostic tests, prevention, some useful therapies and drugs which may effective in treatment.
Other Latest Articles
- Algae Therapy: Highlights on the Pharmaceutical Potentials of Algae
- Drug Therapy Problems among Patients with both Cardiovascular Diseases and Diabetes Mellitus in a Sub-Saharan African Referral Hospital
- COVID 19 in Children
- Exploration of Matrix Metalloproteinase and its Interplay in the Development of Diabetic Nephropathy
- Determinants of Contraceptive Utilization among Married Women
Last modified: 2023-07-14 12:48:12